Related Experiment Video

Updated: Oct 15, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Prospects for vaccination in prostate cancer

M J Perry1, D Hroulda, A G Dalgleish

  • 1Department of Urology and Oncology, St George's Hospital, Medical School, London, England. mnvperry@globalnet.co.uk

Drugs & Aging
|August 5, 2000
PubMed

Insights

Prostate cancer remains a significant health concern. Immunotherapy, a novel treatment, harnesses the immune system to fight cancer, offering new hope for improved survival rates in prostate cancer patients.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Prostate cancer significantly impacts morbidity and mortality.
  • Current treatments offer limited improvements in overall survival.

Purpose of the Study:

  • To review the role of the immune system in malignancy.
  • To explain the theory behind prostate cancer vaccine trials.

Main Methods:

  • Literature review of immunotherapy and prostate cancer.
  • Analysis of immune system's role in cancer.

Main Results:

  • Immunotherapy stimulates a systemic immune response against cancer.
  • Understanding the immune system's interaction with cancer is crucial.

Conclusions:

  • Novel therapies like immunotherapy show promise for prostate cancer treatment.
  • Further research into immune system mechanisms is needed for effective cancer vaccines.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccinations01:51

Vaccinations

Overview
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...